Influenza vaccination strategies: comparing inactivated and live attenuated influenza vaccines

S Sridhar, KA Brokstad, RJ Cox - Vaccines, 2015 - mdpi.com
Influenza is a major respiratory pathogen causing annual outbreaks and occasional
pandemics. Influenza vaccination is the major method of prophylaxis. Currently annual …

Inactivated influenza vaccines

AE Fiore, CB Bridges, JM Katz… - Vaccines. 6th ed …, 2012 - books.google.com
Epidemics and pandemics of respiratory disease consistent with influenza have been
recorded since the 16th century. 1, 2 During the 19th century, influenza was attributed to …

Universal influenza virus vaccines: need for clinical trials

F Krammer, P Palese - Nature immunology, 2014 - nature.com
Universal influenza virus vaccines: need for clinical trials | Nature Immunology Skip to main
content Thank you for visiting nature.com. You are using a browser version with limited support …

Influenza vaccines: challenges and solutions

K Houser, K Subbarao - Cell host & microbe, 2015 - cell.com
Vaccination is the best method for the prevention and control of influenza. Vaccination can
reduce illness and lessen severity of infection. This review focuses on how currently …

Influenza vaccines: Evaluation of the safety profile

CM Trombetta, E Gianchecchi… - Human Vaccines & …, 2018 - Taylor & Francis
The safety of vaccines is a critical factor in maintaining public trust in national vaccination
programs. Vaccines are recommended for children, adults and elderly subjects and have to …

Immune responses to influenza virus infection

J Kreijtz, RAM Fouchier, GF Rimmelzwaan - Virus research, 2011 - Elsevier
Influenza viruses cause annual outbreaks of respiratory tract infection with attack rates of 5–
10%. This means that humans are infected repeatedly with intervals of, on average, 10–20 …

Influenza A virus vaccination: immunity, protection, and recent advances toward a universal vaccine

CE Lopez, KL Legge - Vaccines, 2020 - mdpi.com
Influenza virus infections represent a serious public health threat and account for significant
morbidity and mortality worldwide due to seasonal epidemics and periodic pandemics …

Immunological assessment of influenza vaccines and immune correlates of protection

A Reber, J Katz - Expert review of vaccines, 2013 - Taylor & Francis
Influenza vaccines remain the primary public health tool in reducing the ever-present burden
of influenza and its complications. In seeking more immunogenic, more effective and more …

Influenza vaccines: Past, present, and future

YH Kim, KJ Hong, H Kim… - Reviews in medical …, 2022 - Wiley Online Library
​ Summary Globally, infection by seasonal influenza viruses causes 3–5 million cases of
severe illness and 290,000–650,000 respiratory deaths each year. Various influenza …

Meeting report and review: Immunological assays and correlates of protection for next‐generation influenza vaccines

F Krammer, JP Weir, O Engelhardt… - Influenza and Other …, 2020 - Wiley Online Library
Background This report summarizes the discussions and conclusions from the
“Immunological Assays and Correlates of Protection for Next‐Generation Influenza …